BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025. Three-Month Periods ...

Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering our ...

BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025.

Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025. Three-Month Periods ...

Amedisys operates a national network of 519 care centers, serving nearly half a million patients each year across 38 states and Washington, D.C. Its primary business lines include home health ...

Excluding items, Amedisys reported adjusted earnings of $51.36 million or $1.54 per share for the period. The company's revenue for the period rose 5.2% to $621.86 million from $591.18 million ...

Amedisys shares have climbed slightly more than 7% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $97.52, a fall of roughly 1% in the last 12 months.

Amedisys shares have climbed slightly more than 7% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $97.52, a fall of roughly 1% in the last 12 months.

Amedisys shares have climbed slightly more than 7% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $97.52, a fall of roughly 1% in the last 12 months.